| |
| |
|
| Insider
Information: |
Bell Leonard |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
390,670 |
|
|
Indirect Shares
|
403,285 |
|
|
| Direct
Value |
$71,297,275 |
|
|
|
Indirect Value
|
$73,599,513 |
|
|
| Total
Shares |
793,955 |
|
|
| Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
283 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2015-03-02 |
4 |
S |
$180.34 |
$221,818 |
D/D |
(1,230) |
965,378 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2015-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
22,300 |
966,608 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-02-03 |
4 |
S |
$157.14 |
$458,849 |
D/D |
(2,920) |
972,146 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-29 |
4 |
S |
$133.72 |
$355,929 |
D/D |
(2,660) |
975,066 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-21 |
4 |
AS |
$139.79 |
$15,631,693 |
D/D |
(110,930) |
977,726 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-22 |
4 |
AS |
$141.28 |
$1,812,397 |
D/D |
(12,817) |
977,726 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-02-07 |
4 |
S |
$155.55 |
$718,672 |
D/D |
(4,620) |
986,696 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-22 |
4 |
OE |
$10.29 |
$131,887 |
D/D |
12,817 |
990,543 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
28,040 |
991,316 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-12-05 |
4 |
OE |
$17.98 |
$1,019,844 |
D/D |
56,721 |
1,000,397 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-09-04 |
4 |
AS |
$110.07 |
$203,630 |
D/D |
(1,850) |
1,001,669 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-09-03 |
4 |
AS |
$110.15 |
$3,378,890 |
D/D |
(30,658) |
1,003,519 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-12-08 |
4 |
OE |
$17.98 |
$1,307,156 |
D/D |
59,934 |
1,003,610 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-18 |
4 |
AS |
$161.45 |
$2,000,043 |
D/D |
(12,388) |
1,008,886 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-27 |
4 |
AS |
$169.17 |
$1,000,133 |
D/D |
(5,912) |
1,021,274 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-04 |
4 |
AS |
$165.26 |
$14,321,355 |
D/D |
(85,668) |
1,021,274 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-05 |
4 |
AS |
$161.91 |
$14,876,354 |
D/D |
(90,919) |
1,021,274 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-08 |
4 |
AS |
$165.11 |
$3,502,644 |
D/D |
(21,214) |
1,021,274 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-10 |
4 |
AS |
$165.38 |
$2,017,471 |
D/D |
(12,199) |
1,021,274 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-16 |
4 |
AS |
$159.87 |
$5,136,005 |
D/D |
(32,047) |
1,021,274 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-09-16 |
4 |
AS |
$115.00 |
$402,500 |
D/D |
(3,500) |
1,026,293 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-04 |
4 |
S |
$157.88 |
$812,293 |
D/D |
(5,145) |
1,027,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-12 |
4 |
AS |
$159.92 |
$12,885,910 |
D/D |
(80,458) |
1,027,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-13 |
4 |
AS |
$161.08 |
$3,988,594 |
D/D |
(24,542) |
1,027,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-14 |
4 |
AS |
$165.44 |
$5,807,366 |
D/D |
(35,000) |
1,027,186 |
0 |
- |
|
283 Records found
|
|
Page 8 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
